Assessment of NKG2C Copy Number Variation in HIV-1 Infection Susceptibility, and Considerations About the Potential Role of Lacking Receptors and Virus Infection
Overview
Authors
Affiliations
Human Immunodeficiency Virus (HIV) infection dynamics is strongly influenced by the host genetic background. NKG2C is an activating receptor expressed mainly on Natural Killer (NK) cells, and a polymorphism of copy number variation in the gene coding for this molecule has been pointed as a potential factor involved in HIV infection susceptibility. We evaluated the impact of the NKG2C deletion on HIV-1 susceptibility, with or without HBV/HCV co-infection, in a total of 780 individuals, including 385 HIV-infected patients and 395 healthy blood donors. NKG2C deletion genotyping was performed by standard PCR. To our knowledge, this is the first study to access the impact of complete NKG2C deletion among HIV-infected Brazilian individuals. The frequency of NKG2C deletion (range: 19-22%) was similar in cases and controls. No association of NKG2C deletion with HIV-1 susceptibility or influence on clinical features, HBV or HCV co-infection was observed in the evaluated population. Our findings suggest that NKG2C deletion, and the consequent absence of this receptor expression, does not directly impact HIV susceptibility, HBV/HCV-co-infection in the studied population, suggesting that other signaling pathways might be triggered and perform similar functions in cell activity in the absence of this specific receptor, preventing the development of disadvantageous phenotypes. Larger cohorts and studies involving protein expression are necessary to confirm our findings.
Innate Immune Cell Functions Contribute to Spontaneous HIV Control.
Huber A, Baas F, van der Ven A, Dos Santos J Curr HIV/AIDS Rep. 2024; 22(1):6.
PMID: 39614998 PMC: 11608392. DOI: 10.1007/s11904-024-00713-0.
Siemaszko J, Lacina P, Szymczak D, Szeremet A, Majcherek M, Czyz A Front Immunol. 2023; 14:1227897.
PMID: 37901227 PMC: 10611459. DOI: 10.3389/fimmu.2023.1227897.
Razizadeh M, Zafarani A, Taghavi-Farahabadi M, Khorramdelazad H, Minaeian S, Mahmoudi M Cell Commun Signal. 2023; 21(1):261.
PMID: 37749597 PMC: 10519079. DOI: 10.1186/s12964-023-01266-2.
Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K Arch Immunol Ther Exp (Warsz). 2023; 71(1):9.
PMID: 36899273 PMC: 10004456. DOI: 10.1007/s00005-023-00674-z.